Followers | 246 |
Posts | 49748 |
Boards Moderated | 69 |
Alias Born | 08/29/2007 |
Thursday, April 11, 2024 8:57:36 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent RLYB News
- FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting • Business Wire • 04/17/2024 08:01:00 PM
- Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) • Business Wire • 04/10/2024 08:01:00 PM
- Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting • Business Wire • 04/01/2024 02:05:00 PM
- Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 03/12/2024 12:00:00 PM
- Rallybio to Present at the TD Cowen 44th Annual Health Care Conference • Business Wire • 02/26/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:18:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:15:06 PM
- Rallybio Announces Portfolio Prioritization and Provides Corporate Update • Business Wire • 02/06/2024 01:00:00 PM
- Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024 • Business Wire • 01/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 01:15:28 PM
- Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5 • Business Wire • 12/20/2023 01:00:00 PM
- Rallybio Presents Natural History Study for Fetal and Neonatal Alloimmune Thrombocytopenia at the 65th American Society of Hematology Annual Meeting • Business Wire • 12/09/2023 05:00:00 PM
- Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia • Business Wire • 11/28/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:10:32 PM
- Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates • Business Wire • 11/09/2023 01:00:00 PM
- Rallybio to Present at Upcoming Investor Conferences in November • Business Wire • 11/08/2023 01:00:00 PM
- Rallybio Announces Acceptance of FNAIT Natural History Study Abstract for Presentation at the 65th American Society of Hematology Annual Meeting • Business Wire • 11/02/2023 01:15:00 PM
- Rallybio to Present at the JonesTrading 2023 Healthcare Summit • Business Wire • 10/03/2023 12:00:00 PM
- Rallybio Presents Phase 1 Single Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5 • Business Wire • 09/03/2023 04:00:00 PM
- Rallybio to Present at Upcoming Investor Conferences in September • Business Wire • 08/31/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:18:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 12:16:08 PM
- Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates • Business Wire • 08/08/2023 12:00:00 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM